Results 121 to 130 of about 141,456 (190)

Are joint replacement registries cost-effective? Economic evaluation of the Australian orthopaedic association National joint replacement registry. [PDF]

Arch Orthop Trauma Surg
Okafor C, Nghiem S, Holder C, Vertullo C, Byrnes J.   +4 more
europepmc   +1 more source

Cost-effectiveness of implantable cardioverter-defibrillators for primary prevention in heart failure with reduced ejection fraction: a Markov model using JROAD-DPC cost data in Japan. [PDF]

Front Cardiovasc Med
Ohashi K, Watanabe M, Morii Y, Yokoshiki H, Kusano K, Imai K, Takagi M, Yamane T, Tada H, Ogasawara K.   +9 more
europepmc   +1 more source

Allocative efficiency analysis of strategies to reduce overdose deaths among people with opioid use disorder and history of incarceration in Connecticut. [PDF]

BMC Public Health
Scheidell JD, Frechette JM, Townsend TN, Zhou Q, Manandhar-Sasaki P, Fiellin DA, Heimer R, Puglisi LB, Charles DL, Su JI, Biegacki ET, Braithwaite RS.   +11 more
europepmc   +1 more source

Lifetime cost-effectiveness of lecanemab for early Alzheimer's disease. [PDF]

Front Public Health
Jiang X, Lv G, Mendes ME, Wu J, Yuan J, Lu ZK.   +5 more
europepmc   +1 more source

Cost effectiveness analysis of prostate cancer screening strategies in Germany: A microsimulation study. [PDF]

Int J Cancer
Muchadeyi MT, Hao S, Hernandez-Villafuerte K, Khan SA, Becker N, Krilaviciute A, Seibold P, Gulati R, Albers P, Schlander M, Clements M.   +10 more
europepmc   +1 more source

Discrete Event Simulation in R using the 'Simmer' Package for Health Economic Modelling: A Tutorial and Illustration in Colon Cancer. [PDF]

Appl Health Econ Health Policy
Degeling K, Karnon J, van de Ven M, Brennan A, Koffijberg H.   +4 more
europepmc   +1 more source

A systematic review of the current application status of decision-analytical models in the pharmacoeconomic evaluation of targeted therapies for pulmonary arterial hypertension. [PDF]

Cost Eff Resour Alloc
Dong W, Zhang Z, Wang X, Ma X, Chu M, Li Y, Xiang X, Peng C, Zhang R.   +8 more
europepmc   +1 more source

Methodological challenges in Dutch HTA of non-oncological orphan drugs: a retrospective analysis and price comparison using different pricing models. [PDF]

Orphanet J Rare Dis
Walraven J, Kaveh M, Uyl-de Groot C.
europepmc   +1 more source

Cost Utility Modeling of Reducing Waiting Times for Elective Surgical Interventions: Case Study of Egyptian Initiative. [PDF]

Healthcare (Basel)
Nader Fasseeh A, Salem AA, Khalifa AY, ElBerri AK, Abaza N, Elezbawy B, Al Qasseer N, Nagy B, Kaló Z, Németh B, Hren R.   +10 more
europepmc   +1 more source

A Cost-Effectiveness Analysis of the Sentio Bone Conduction Hearing Implant System in the Australian Healthcare Setting. [PDF]

J Mark Access Health Policy
Värendh M, Haggren I, Lagerkvist H, Åberg Håkansson M, Hjelmgren J.   +4 more
europepmc   +1 more source